Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Chronic obstructive pulmonary disease
ADR ID BADD_A00935
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.03      Bronchial disorders (excl neoplasms)
22.03.01      Bronchospasm and obstruction
22.03.01.007      Chronic obstructive pulmonary disease
Description A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. [MeSH]
MedDRA Code 10009033
MeSH ID D029424; D029424; D029424
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Chronic airflow limitation | Chronic airway obstruction, not elsewhere classified | Chronic airways obstruction, not elsewhere classified | Chronic bronchitis & emphysema | Chronic obstruct airways disease | Chronic obstructive airways disease | Chronic obstructive airways disease exacerbated | Chronic obstructive lung disease | Chronic obstructive pulmonary disease | COAD | COAD exacerbated | COPD | COPD exacerbation | Obstructive airways disease (chronic) | Smoker's lung | Chronic obstructive bronchopneumopathy | Chronic obstructive pulmonary disease exacerbation | End stage COPD | Emphysematous COPD | Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease | Chronic Obstructive Airway Disease | Chronic Obstructive Lung Disease | Airflow Obstruction, Chronic | Airflow Obstructions, Chronic | Chronic Airflow Obstructions | Chronic Airflow Obstruction
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02232Tobramycin0.001644%
BADD_D02236Tofacitinib0.018638%
BADD_D02259Trandolapril--
BADD_D02268Treprostinil0.001563%
BADD_D02314Umeclidinium0.000897%
BADD_D02331Valsartan0.000265%
BADD_D02337Varenicline0.007203%
BADD_D02369Voriconazole0.020330%
BADD_D02370Vorinostat0.000112%
BADD_D02375Water--
BADD_D02392Zoledronic acid0.014315%
BADD_D02407Upadacitinib0.003761%
BADD_D02412Octreotide0.000186%
BADD_D02432Glycopyrronium0.013618%
BADD_D02443Tiotropium0.010127%
BADD_D02445Solifenacin0.000174%
BADD_D02452Icatibant-
BADD_D02465Aclidinium0.009853%
BADD_D02470Nintedanib0.000448%
BADD_D02471Oxygen0.003098%
BADD_D02480Alectinib0.000280%
BADD_D02483Ribociclib0.000224%
BADD_D02487Baricitinib0.000241%
BADD_D02497Avatrombopag0.000229%
BADD_D02504Lorlatinib0.000168%
BADD_D02574Molnupiravir0.000565%
BADD_D02580Ozanimod0.001061%
BADD_D02591Ripretinib0.000112%
BADD_D02596Sotorasib0.000492%
The 5th Page    First    Pre   5    Total 5 Pages